Literature DB >> 27177748

Ginsenoside Rh2 inhibits proliferation and induces apoptosis in human leukemia cells via TNF-α signaling pathway.

Jingjia Huang1, Kunjian Peng1, Linghao Wang1, Bin Wen1, Lin Zhou1, Tiao Luo1, Min Su1, Jijia Li1, Zhiyong Luo2.   

Abstract

Ginsenoside Rh2, a triterpene saponin extracted from Panax ginseng, exhibits pharmacological activity against multiple cancers. However, the anticancer mechanism of ginsenoside Rh2 is unclear. In this study, we found that ginsenoside Rh2 effectively inhibits growth and induces apoptosis of HL-60 cells. Using microarray technology, we found that tumor necrosis factor-α (TNF-α) is clearly up-regulated. Furthermore, anti-TNF-α antibody relieved the Rh2-induced HL-60 cell apoptosis via suppression of caspase-8, caspase-9, and caspase-3 activation. In addition, TNF-α up-regulation was also observed in other Rh2-treated cancer cell lines. These results demonstrate that TNF-α plays a key role in ginsenoside Rh2-induced cell apoptosis.
© The Author 2016. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  apoptosis; ginsenoside Rh2; microarray; tumor necrosis factor-α

Mesh:

Substances:

Year:  2016        PMID: 27177748     DOI: 10.1093/abbs/gmw049

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  8 in total

1.  MicroRNA-146a-5p enhances ginsenoside Rh2-induced anti-proliferation and the apoptosis of the human liver cancer cell line HepG2.

Authors:  Weiwen Chen; Shuai Chu; Haixia Li; Yurong Qiu
Journal:  Oncol Lett       Date:  2018-07-31       Impact factor: 2.967

2.  Long noncoding RNAs and novel inflammatory genes determined by RNA sequencing in human lymphocytes are up-regulated in permanent atrial fibrillation.

Authors:  Xue-Jing Yu; Li-Hui Zou; Jun-Hua Jin; Fei Xiao; Li Li; Nan Liu; Jie-Fu Yang; Tong Zou
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

3.  20(S)-Ginsenoside Rh2 Induce the Apoptosis and Autophagy in U937 and K562 Cells.

Authors:  Jianjian Zhuang; Juxin Yin; Chaojian Xu; Ying Mu; Shaowu Lv
Journal:  Nutrients       Date:  2018-03-08       Impact factor: 5.717

4.  Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.

Authors:  Honglin Li; Nan Huang; Weikang Zhu; Jianchun Wu; Xiaohui Yang; Wenjing Teng; Jianhui Tian; Zhihong Fang; Yingbin Luo; Min Chen; Yan Li
Journal:  BMC Cancer       Date:  2018-05-22       Impact factor: 4.430

Review 5.  Saponins from Chinese Medicines as Anticancer Agents.

Authors:  Xiao-Huang Xu; Ting Li; Chi Man Vivienne Fong; Xiuping Chen; Xiao-Jia Chen; Yi-Tao Wang; Ming-Qing Huang; Jin-Jian Lu
Journal:  Molecules       Date:  2016-10-05       Impact factor: 4.411

6.  20(S)-ginsenoside Rh2 induces caspase-dependent promyelocytic leukemia-retinoic acid receptor A degradation in NB4 cells via Akt/Bax/caspase9 and TNF-α/caspase8 signaling cascades.

Authors:  Sirui Zhu; Xiaoli Liu; Mei Xue; Yu Li; Danhong Cai; Shijun Wang; Liang Zhang
Journal:  J Ginseng Res       Date:  2020-05-15       Impact factor: 6.060

7.  Ginsenoside Rh2 upregulates long noncoding RNA STXBP5-AS1 to sponge microRNA-4425 in suppressing breast cancer cell proliferation.

Authors:  Jae Eun Park; Hyeon Woo Kim; Sung Hwan Yun; Sun Jung Kim
Journal:  J Ginseng Res       Date:  2021-08-27       Impact factor: 6.060

8.  20(S)-ginsenoside Rh2 as agent for the treatment of LMN-CRC via regulating epithelial-mesenchymal transition.

Authors:  Yihang Yuan; Jue Wang; Ming Xu; Yunpeng Zhang; Zhiqiang Wang; Leilei Liang; Peng Sun
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.